BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

892 related articles for article (PubMed ID: 16489840)

  • 1. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
    Tan HH; Goh CL
    Am J Clin Dermatol; 2006; 7(1):13-29. PubMed ID: 16489840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral skin infections in the elderly: diagnosis and management.
    Bansal R; Tutrone WD; Weinberg JM
    Drugs Aging; 2002; 19(7):503-14. PubMed ID: 12182687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugs.
    Brown TJ; McCrary M; Tyring SK
    J Am Acad Dermatol; 2002 Oct; 47(4):581-99. PubMed ID: 12271305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
    Reusser P
    J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections caused by herpes viruses other than cytomegalovirus in solid organ transplant recipients.
    Carratalà J; Montejo M; Pérez-Romero P
    Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():63-9. PubMed ID: 22542037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral prophylaxis in organ transplant patients.
    Slifkin M; Doron S; Snydman DR
    Drugs; 2004; 64(24):2763-92. PubMed ID: 15563248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous viral infections in organ transplant patients.
    Piaserico S; Sandini E; Peserico A; Alaibac M
    G Ital Dermatol Venereol; 2014 Aug; 149(4):409-15. PubMed ID: 25068228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis against herpesvirus infections in transplant recipients.
    Ljungman P
    Drugs; 2001; 61(2):187-96. PubMed ID: 11270937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA viruses (CMV, EBV, and the herpesviruses).
    Zamora MR
    Semin Respir Crit Care Med; 2011 Aug; 32(4):454-70. PubMed ID: 21858750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
    Voigt S; Hofmann J; Edelmann A; Sauerbrei A; Kühl JS
    Transpl Infect Dis; 2016 Oct; 18(5):791-794. PubMed ID: 27482652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral lesions of the mouth in HIV-infected patients.
    Itin PH; Lautenschlager S
    Dermatology; 1997; 194(1):1-7. PubMed ID: 9031782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
    Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
    Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in herpesvirus therapy.
    Naesens L; De Clercq E
    Herpes; 2001 Mar; 8(1):12-6. PubMed ID: 11867011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antivirals for the treatment of herpesvirus infections.
    De Clercq E
    J Antimicrob Chemother; 1993 Jul; 32 Suppl A():121-32. PubMed ID: 8407694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.
    Mullane KM; Nuss C; Ridgeway J; Prichard MN; Hartline CB; Theusch J; Mommeja-Marin H; Larson RA
    Transpl Infect Dis; 2016 Oct; 18(5):785-790. PubMed ID: 27481400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D; Scott LJ; Perry CM
    Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpesviruses.
    Bowers M
    BETA; 1995 Dec; ():33-7. PubMed ID: 11363008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.